Skip to main content
. Author manuscript; available in PMC: 2021 Aug 10.
Published in final edited form as: J Clin Oncol. 2020 May 4;38(23):2620–2627. doi: 10.1200/JCO.19.02727

FIG 3.

FIG 3.

Interferon g (IFNγ) signature, by best percentage change from baseline in sum of diameters of target lesions. Best overall response by RECIST v1.1 is indicated. Data were available for 18 patients. Spearman coefficient, −0.67; 95% CI, −0.9 to −0.3. CR, complete response; PD, progressive disease; PD-L1, programmed death-ligand 1; PR, partial response; SD, stable disease.